Table 2 Multivariate analysis of the predictive factors of KDIGO stage 2–3 acute kidney injury in patients with severe rhabdomyolysis
Model 1 [AUC 0.81] [Hosmer–Lemeshow test 0.31] | Model 2 [AUC 0.82] [Hosmer–Lemeshow test 0.51] | |||
|---|---|---|---|---|
Hazard ratio [IC5–95%] | p value | Hazard ratio [IC5–95%] | p value | |
Serum phosphorus (per mmol/L) | 2.2 [1.6–4.9] | 0.0004 | 2.8 [1.4–5.6] | 0.003 |
Serum calcium (per mmol/L) | 2.37 [0.7–8.3] | 0.18 | – | – |
Myoglobin (> 8000 U/L at admission) | – | – | 2.03 [1.01–4.1] | 0.02 |
Creatine phosphokinase (per 1000 UI/L) | 1.01 [0.99–1.03] | 0.09 | – | – |
Serum potassium (per mmol/L) | 1.5 [1.1–2.0] | 0.02 | 1.7 [1.2–2.4] | 0.003 |
Bicarbonates (mmol/L) | 0.92 [0.86–0.99] | 0.03 | 0.95 [0.88–1.02] | 0.18 |
Vasoactive drugs | 1.9 [0.8–4.3] | 0.12 | 1.8 [0.8–4.1] | 0.16 |
Mechanical ventilation | 2.4 [1.05–5.5] | 0.04 | 1.9 [0.8–4.6] | 0.12 |
Prothrombin time (%) | 0.99 [0.97–1.01] | 0.20 | – | – |